Cancer-associated mutations reveal a novel role for EpCAM as an inhibitor of cathepsin-L and tumor cell invasion
Narendra V. Sankpal(Washington University in St. Louis), William E. Gillanders(Washington University in St. Louis)
Cited by 14
Related Papers
Activator protein 1 (AP-1) contributes to EpCAM-dependent breast cancer invasion
|Breast Cancer Research|2011|53
Cytosolic EpCAM cooperates with H-Ras to regulate epithelial to mesenchymal transition through ZEB1
|PLoS ONE|2023|4